People · Operator
Named in public records as an officer, director or promoter · active 2022–2024 · Other Technology
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| LevitasBio, Inc. | — | Other Technology | Series B | $73.8M | $96.2M | 2022 |
Steve Tablak at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Steve Tablak on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Paul Meister | 1 | 12 |
| Victor Tong | 1 | 6 |
| Xiangmin Cui | 1 | 3 |
| Greg Herrema | 1 | 1 |
| Sandy Gardiner | 1 | 1 |
| Martin Pieprzyk | 1 | 1 |
| Victor E. Tong, Jr. | 1 | 1 |
| Lars Steinmetz | 1 | 1 |
| Zheng E. Wang | 1 | 1 |
| Utkan Demirci | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.